• Blog
  • About
  • Partners
  • Contact
  • Fundraise
Give Now »
Young Survival Coalition logo
    • Learn
      • About Breast Cancer
        • Breast Cancer 101
        • Breast Cancer Statistics
        • Breast Cancer Risk Factors
        • FAQs
      • Living With Breast Cancer
        • Understanding Treatment
        • Quality of Life
        • Fertility and Family Planning
        • Practical Concerns
        • Clinical Trials
      • Metastatic Breast Cancer
        • Metastatic Breast Cancer Diagnosis
        • Metastatic Breast Cancer Treatment
        • Living with Metastatic Breast Cancer
        • Metastatic Clinical Trial Search
        • Metastatic Breast Cancer Resources
      • Resources and Tools
        • Search for Resources
        • Audio/Video Library
        • Educational Materials
        • Partner Resources
      • Co-Survivors
        • Self-Care
        • How To Help
        • Co-Survivor
          Community
      • Research
        • Research Agenda
        • Position Papers
        • Metastatic Survey
      • En Español
    • Connect
      • Find Support Online
        • Virtual Hangouts
        • Private Facebook Groups
      • Meet In Person
        • Local Meetups
        • Conferences
      • Talk One-On-One
    • Get Involved
      • Volunteer
      • Attend A Conference
      • Be An Advocate
      • Fundraise or Host an Event
      • Ride in Tour de Pink
      • Pledge Your Birthday
      • Upcoming Events
      • #TitCheck BCA Campaign
    • Be Inspired
    • Donate
      • Make a Donation
      • Fundraise for YSC
      • All Ways to Give
Young Survival Coalition logo

Mobile Menu

Young Survival Coalition logo
  • Blog
  • About
  • Partners
  • Contact
  • Fundraise
  • Learn
    • About Breast Cancer
      • Breast Cancer 101
      • Breast Cancer Statistics
      • Breast Cancer Risk Factors
      • FAQs
    • Living With Breast Cancer
      • Understanding Treatment
      • Quality of Life
      • Fertility and Family Planning
      • Practical Concerns
      • Clinical Trials
    • Metastatic Breast Cancer
      • Metastatic Breast Cancer Diagnosis
      • Metastatic Breast Cancer Treatment
      • Living with Metastatic Breast Cancer
      • Metastatic Clinical Trial Search
      • Metastatic Breast Cancer Resources
    • Resources and Tools
      • Search for Resources
      • Audio/Video Library
      • Educational Materials
      • Partner Resources
    • Co-Survivors
      • Self-Care
      • How To Help
      • Co-Survivor
        Community
    • Research
      • Research Agenda
      • Position Papers
      • Metastatic Survey
    • En Español
  • Connect
    • Find Support Online
      • Virtual Hangouts
      • Private Facebook Groups
    • Meet In Person
      • Local Meetups
      • Conferences
    • Talk One-On-One
  • Get Involved
    • Volunteer
    • Attend A Conference
    • Be An Advocate
    • Fundraise or Host an Event
    • Ride in Tour de Pink
    • Pledge Your Birthday
    • Upcoming Events
    • #TitCheck BCA Campaign
  • Be Inspired
  • Donate
    • Make a Donation
    • Fundraise for YSC
    • All Ways to Give

Menu: Research Think Tank Treatment Work Group

  • About Breast Cancer
    • Breast Cancer 101
      • Breast Cancer Diagnosis
      • Breast Cancer Staging
      • Breast Cancer Symptoms
      • Types of Breast Cancer
    • Metastatic Breast Cancer
      • Metastatic Breast Cancer Diagnosis
    • Breast Cancer Statistics
    • Breast Cancer Risk Factors
  • Living with Breast Cancer
    • Understanding Treatment
      • Breast Cancer Treatment
      • Breast Reconstruction
      • Post-Treatment Care
      • Understanding Pathology Results
      • Your Healthcare Team
    • Living with Metastatic Breast Cancer
      • MBC Treatment
      • Metastatic Clinical Trials
        • Metastatic Trial Search
      • MBC Organizations and Resources
    • Quality of Life
      • Managing Side Effects
        • Bone Health
        • Chemo Brain
        • Early Menopause
        • Fatigue
        • Lymphedema
        • Pain
      • Sex and Intimacy
      • Communicating with Children
      • Mental Health
      • Wellness
        • Nutrition
        • Stress Management
        • Weight and Exercise
      • Long-Term Survivorship
    • Fertility and Family Planning
      • Fertility Preservation
      • Options After Treatment
      • Other Family Planning Resources
      • Treatment Impact on Fertility
    • Practical Concerns
      • Careers
      • End of Life Planning
      • Financial Assistance
      • Health Insurance
  • Resources and Tools
    • Audio Video Library
    • Educational Materials
    • Partner Resources
  • Co-Survivors
    • How to Help
    • Our Co-Survivor Community
    • Self-Care
  • Research
    • Research Think Tank Fertility Work Group
    • Research Think Tank Metastasis Work Group
    • Research Think Tank Pregnancy Work Group
    • Research Think Tank Quality of Life Work Group
    • Research Think Tank Risk Factors Work Group
    • Research Think Tank Treatment Work Group
    • YSC Research Agenda
    • Clinical Trials
    • Position Papers
    • Metastatic Survey Results
  • Newly Diagnosed Navigator
  • Metastatic Navigator
  • Post-Treatment Navigator
  • Long Term Navigator
Share

Research Think Tank Treatment

Research Think Tank on treatment.

The Research Think Tank (RTT) Treatment Work Group focused on unanswered questions about the most optimal treatment of breast cancer in a young woman and how that treatment may differ from that given to an older woman.

The group was composed of advocates:

  • Kimberly Hagerich (chair)
  • Leslie Hammersmith
  • Hannah Klein Connolly
  • Tracy Leduc
  • Debra Madden
  • Elizabeth Wohl

As well as physicians/researchers:

  • Dr. Ann Partridge
  • Dr. Alexander Swistel

Research Think Tank on cancer treatment.

Research Priorities

Six of the 19 research priorities recommended by the RTT focused on treatment of breast cancer in young women. Below we list the priority, indicate any progress made since the RTT and list any open trials of which we are aware related to or focusing on these research priorities.

Are there specific factors in the tumor microenvironment of young women with breast cancer that contribute to worse prognosis, alter treatment response and increase risk for local recurrence, distant relapse and decreased overall survival?

Progress Made: In Progress


Recent research updates:

Young women’s microenvironment (stroma) may have a role in breast cancer growth, particularly in triple negative breast cancer. Read More

Current research initiatives/studies:

Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response. Read More


In what context should younger women with breast cancer receive more aggressive treatments?

Progress Made: Thumbs Down


Recent research updates:

A recent study found a possible mechanism by which postpartum breast cancer is more aggressive and likely to metastasize. Read More


What are the optimal chemotherapy and targeted therapy regimens for each tumor type in young women? In what contexts should neoadjuvant chemotherapy be considered in young women?

Progress Made: Thumbs Up


Recent research updates:

A study examining neoadjuvant chemotherapy in young women found that young women, especially those with hormone receptor positive/HER2- and triple negative breast cancer, were more likely to achieve complete pathological response (pCR, breast cancer disappears), and young women with luminal-like breast cancer appeared to benefit more from neoadjuvant chemotherapy than older women. Read More


When is ovarian suppression (GnRH agonist or oophorectomy) appropriate in the treatment of young women with ER+ disease? Is inducing menopause in young women a valid treatment approach?

Progress Made: Thumbs Up


Recent research updates:

SOFT and TEXT trial data showed that ovarian suppression in combination with Tamoxifen or an Aromatase Inhibitor reduces breast cancer recurrence in young women, age 35 or younger, who were at high risk of recurrence (high enough risk that chemotherapy was ordered). Read More


In the long-term, which surgical option (mastectomy or lumpectomy with radiation) provides the best overall survival for young women? Does local recurrence impact survival in young women?

Progress Made: Work in Progress


Recent research updates:

There have been two recent, conflicting, studies on the long-term outcomes of mastectomy versus lumpectomy plus radiation. ESTRO reported that lumpectomy plus radiation therapy showed higher rates of recurrence in women under age 45 (compared to mastectomy), and that recurrence was more likely to lead to metastasis. It is important to recognize that this study’s observational data was collected in 1989-1998 and none of the women received systemic therapies, which is not representative of the current standard of care. Read More

A recent meta-analysis did not find a significant survival difference between lumpectomy plus radiation therapy and mastectomy in women age 40 and younger. Read More


How can we identify young women who may be candidates for endocrine therapy alone versus combined adjuvant or neoadjuvant chemotherapy with endocrine therapy? What is the optimal type/duration of endocrine therapy?

Progress Made: Thumbs Up


Recent research updates:

Oncotype DX is a test which shows which women can safely avoid chemotherapy and receive endocrine therapy only. A recent report of Oncotype DX data, which included data for women under 40, showed that a recurrence score less than 18 had no significant differences in outcomes compared to the 40-49 and 50-59 age groups. In the younger patients with node-negative disease and recurrence score <18, Breast Cancer Specific Mortality was <1.3% and those with node-positive was <1.7%. Read More

Recent studies have indicated that 10 years of tamoxifen is better than 5 at reducing the risk of recurrence in young premenopausal women with hormone receptor positive breast cancer. Read More

Please refer to the SOFT and TEXT trial results above for information on possible ovarian suppression as well.

Current research initiatives/studies:

The POSITIVE Trial is examining whether it is safe to take a “baby break” from Tamoxifen so that a woman can conceive a child and the length of time that Tamoxifen should be taken before the “baby break” occurs.

Read More

Read about our RTT work group on quality of life during and after breast cancer treatment.

If you believe we are missing a crucial piece of research or have not included a research study which should be here, please contact us!

Related Topics

Research Think Tank Risk Factors Work Group

Research Think Tank Risk Factors Work Group

The Research Think Tank (RTT) Risk Factors Work Group focused on unanswered questions about what increases the risk of young women developing breast cancer. These risk factors likely differ from what causes the disease in older women.
Research Think Tank Quality of Life Work Group

Research Think Tank Quality of Life Work Group

The Research Think Tank (RTT) Quality of Life Work Group focused on unanswered questions about a young woman's life and side effects during and after breast cancer treatment.
Research Think Tank Pregnancy Work Group

Research Think Tank Pregnancy Work Group

The Research Think Tank (RTT) Pregnancy Work Group focused on unanswered questions relating to all aspects of breast cancer and pregnancy. These included breast cancer treatment during pregnancy, postpartum breast cancer and the safety of pregnancy after breast cancer.
Research Think Tank Metastasis Work Group

Research Think Tank Metastasis Work Group

The Research Think Tank (RTT) Metastasis Work Group focused on the unique issues and concerns of young women diagnosed with metastatic breast cancer.

Research Think Tank Fertility Work Group

The Research Think Tank (RTT) Fertility Work Group focused on unanswered questions relating to a young woman maintaining her fertility throughout breast cancer treatment. It also addressed the use and safety of fertility preservation.

Search for Resources

Audio & Video Library

Educational Materials

Conferences

  • About YSC
  • FAQs
  • Careers
  • Media Center
  • Contact

Young Survival Coalition is a qualified 501(c)(3) tax exempt nonprofit organization dedicated to all young breast cancer survivors and their co-survivor support networks. YSC's EIN is 13-4057685.


405 Lexington Avenue, 26th Floor | New York, NY 10174 | phone: 877.972.1011 | fax: 646.257.3030

© 1998-2023 Young Survival Coalition. All rights reserved. Privacy Policy | Terms of Service | website design by efelle